188 related articles for article (PubMed ID: 19275204)
1. Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.
Grubb RL; Deng J; Pinto PA; Mohler JL; Chinnaiyan A; Rubin M; Linehan WM; Liotta LA; Petricoin EF; Wulfkuhle JD
J Proteome Res; 2009 Jun; 8(6):3044-54. PubMed ID: 19275204
[TBL] [Abstract][Full Text] [Related]
2. Signal pathway profiling of prostate cancer using reverse phase protein arrays.
Grubb RL; Calvert VS; Wulkuhle JD; Paweletz CP; Linehan WM; Phillips JL; Chuaqui R; Valasco A; Gillespie J; Emmert-Buck M; Liotta LA; Petricoin EF
Proteomics; 2003 Nov; 3(11):2142-6. PubMed ID: 14595813
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
[TBL] [Abstract][Full Text] [Related]
4. A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.
Pin E; Stratton S; Belluco C; Liotta L; Nagle R; Hodge KA; Deng J; Dong T; Baldelli E; Petricoin E; Pierobon M
Mol Oncol; 2016 Dec; 10(10):1585-1594. PubMed ID: 27825696
[TBL] [Abstract][Full Text] [Related]
5. Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.
Tyekucheva S; Bowden M; Bango C; Giunchi F; Huang Y; Zhou C; Bondi A; Lis R; Van Hemelrijck M; Andrén O; Andersson SO; Watson RW; Pennington S; Finn SP; Martin NE; Stampfer MJ; Parmigiani G; Penney KL; Fiorentino M; Mucci LA; Loda M
Nat Commun; 2017 Sep; 8(1):420. PubMed ID: 28871082
[TBL] [Abstract][Full Text] [Related]
6. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.
Di Vizio D; Morello M; Sotgia F; Pestell RG; Freeman MR; Lisanti MP
Cell Cycle; 2009 Aug; 8(15):2420-4. PubMed ID: 19556867
[TBL] [Abstract][Full Text] [Related]
7. SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation.
Heebøll S; Borre M; Ottosen PD; Andersen CL; Mansilla F; Dyrskjøt L; Orntoft TF; Tørring N
Histol Histopathol; 2008 Sep; 23(9):1069-76. PubMed ID: 18581278
[TBL] [Abstract][Full Text] [Related]
8. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
Improta G; Zupa A; Fillmore H; Deng J; Aieta M; Musto P; Liotta LA; Broaddus W; Petricoin EF; Wulfkuhle JD
J Proteome Res; 2011 Jul; 10(7):3089-97. PubMed ID: 21574647
[TBL] [Abstract][Full Text] [Related]
9. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
10. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.
Nariculam J; Freeman A; Bott S; Munson P; Cable N; Brookman-Amissah N; Williamson M; Kirby RS; Masters J; Feneley M
Asian J Androl; 2009 Jan; 11(1):109-18. PubMed ID: 19050681
[TBL] [Abstract][Full Text] [Related]
11. Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlates.
Thakkar A; Bijnsdorp IV; Geldof AA; Shah GV
Oncol Rep; 2013 Sep; 30(3):1265-74. PubMed ID: 23820954
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A.
Bhattacharyya S; Feferman L; Tobacman JK
Prostate; 2019 May; 79(7):689-700. PubMed ID: 30801800
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
14. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
16. Expression of tSTAT3, pSTAT3
Krzyzanowska A; Don-Doncow N; Marginean FE; Gaber A; Watson RW; Hellsten R; Bjartell A
Prostate; 2019 May; 79(7):784-797. PubMed ID: 30905090
[TBL] [Abstract][Full Text] [Related]
17. Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases.
Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
Mod Pathol; 2006 Jul; 19(7):931-41. PubMed ID: 16575399
[TBL] [Abstract][Full Text] [Related]
18. Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.
Hägglöf C; Hammarsten P; Josefsson A; Stattin P; Paulsson J; Bergh A; Ostman A
PLoS One; 2010 May; 5(5):e10747. PubMed ID: 20505768
[TBL] [Abstract][Full Text] [Related]
19. Integrative molecular concept modeling of prostate cancer progression.
Tomlins SA; Mehra R; Rhodes DR; Cao X; Wang L; Dhanasekaran SM; Kalyana-Sundaram S; Wei JT; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Nat Genet; 2007 Jan; 39(1):41-51. PubMed ID: 17173048
[TBL] [Abstract][Full Text] [Related]
20. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
Sharpe B; Alghezi DA; Cattermole C; Beresford M; Bowen R; Mitchard J; Chalmers AD
Prostate; 2017 May; 77(13):1312-1324. PubMed ID: 28744948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
